An assessment of the documentation for 30 over-the-counter diagnostic tests found none met the current regulatory standards.

The blood test is designed to detect the accumulation of amyloid protein deposits in the brain, a hallmark of Alzheimer's disease.

An assessment of the documentation for 30 over-the-counter diagnostic tests found none met the current regulatory standards.

China sales were down 26 percent in the first half of the year due to volume-based procurement programs and healthcare pricing reforms in China.

NEW YORK – Laboratory Corporation of America reported on Thursday morning that its second quarter revenues jumped almost 10 percent from a year ago, prompting the firm to raise its full-year revenue ...

The test was developed in collaboration with Eli Lilly and can be used with other clinical information to rule out Alzheimer's disease as the cause of cognitive decline.

The cash deal includes ambulatory outreach laboratory services in 13 states and includes patient service centers and in-office phlebotomy sites.

The investment bank said that Exagen is poised for growth with a differentiated autoimmune test that outperforms conventional biomarker-based tests.